Optimal application method of a moisturizer on the basis of skin physiological functions.


Journal

Journal of cosmetic dermatology
ISSN: 1473-2165
Titre abrégé: J Cosmet Dermatol
Pays: England
ID NLM: 101130964

Informations de publication

Date de publication:
Jul 2022
Historique:
revised: 13 09 2021
received: 10 08 2021
accepted: 28 09 2021
pubmed: 8 11 2021
medline: 20 7 2022
entrez: 7 11 2021
Statut: ppublish

Résumé

Clinical studies have clarified the usefulness of moisturizers for dry skin diseases. However, few reports exist on the appropriate application of moisturizers with respect to the skin physiological functions. To clarify the optimal moisturizer application method on the basis of skin physiological functions. This study investigated the appropriate time, dose, and frequency of moisturizer application from the perspective of skin physiology. In healthy subjects, the stratum corneum water content (SCW) was compared between different moisturizer application times (immediately [≤5 min] and 90 min after bathing), doses (0.5, 1.0, and 2.0 mg/cm In healthy subjects, compared to at control sites, the SCW was significantly higher at sites treated with the moisturizer immediately after bathing, with 1.0 and 2.0 mg/cm Moisturizer application of ≥1.0 mg/cm

Sections du résumé

BACKGROUND BACKGROUND
Clinical studies have clarified the usefulness of moisturizers for dry skin diseases. However, few reports exist on the appropriate application of moisturizers with respect to the skin physiological functions.
AIMS OBJECTIVE
To clarify the optimal moisturizer application method on the basis of skin physiological functions.
METHODS METHODS
This study investigated the appropriate time, dose, and frequency of moisturizer application from the perspective of skin physiology. In healthy subjects, the stratum corneum water content (SCW) was compared between different moisturizer application times (immediately [≤5 min] and 90 min after bathing), doses (0.5, 1.0, and 2.0 mg/cm
RESULTS RESULTS
In healthy subjects, compared to at control sites, the SCW was significantly higher at sites treated with the moisturizer immediately after bathing, with 1.0 and 2.0 mg/cm
CONCLUSIONS CONCLUSIONS
Moisturizer application of ≥1.0 mg/cm

Identifiants

pubmed: 34743412
doi: 10.1111/jocd.14560
pmc: PMC9543289
doi:

Substances chimiques

Desmoglein 1 0
Emollients 0
Water 059QF0KO0R

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3095-3101

Subventions

Organisme : TOKIWA Pharmaceutical Co., Ltd.

Informations de copyright

© 2021 The Authors. Journal of Cosmetic Dermatology published by Wiley Periodicals LLC.

Références

J Cosmet Dermatol. 2022 Jul;21(7):3095-3101
pubmed: 34743412
Br J Dermatol. 1996 Mar;134(3):460-4
pubmed: 8731669
Allergy. 2010 Sep;65(9):1166-72
pubmed: 20374230
J Dtsch Dermatol Ges. 2019 Nov;17 Suppl 7:3-33
pubmed: 31738016
J Cosmet Dermatol. 2020 Jun;19(6):1528-1534
pubmed: 31617666
Drugs Context. 2018 Apr 17;7:212530
pubmed: 29692852
J Allergy Clin Immunol. 2014 Oct;134(4):824-830.e6
pubmed: 25282564
J Dermatol. 2016 Oct;43(10):1117-1145
pubmed: 27076388
Clin Exp Immunol. 2013 Mar;171(3):330-7
pubmed: 23379440
Skin Pharmacol Appl Skin Physiol. 1999 Jul-Aug;12(4):182-92
pubmed: 10420138
J Invest Dermatol. 2004 May;122(5):1235-44
pubmed: 15140227
Pediatr Dermatol. 2009 May-Jun;26(3):273-8
pubmed: 19706087
J Dermatol Sci. 2010 Mar;57(3):192-8
pubmed: 20116975
Proc Natl Acad Sci U S A. 2012 Oct 16;109(42):17111-6
pubmed: 23027968
J Dermatol. 2004 Aug;31(8):603-9
pubmed: 15492432
Dermatol Ther. 2003;16(3):254-9
pubmed: 14510882
J Cosmet Dermatol. 2010 Mar;9(1):16-21
pubmed: 20367668
Allergol Int. 2017 Apr;66(2):230-247
pubmed: 28209325
J Cosmet Dermatol. 2020 Oct;19(10):2650-2655
pubmed: 31990110
J Am Acad Dermatol. 2003 Mar;48(3):352-8
pubmed: 12637914
J Cosmet Dermatol. 2006 Jun;5(2):140-9
pubmed: 17173589

Auteurs

Yukiko Ueda (Y)

New Ueda Clinic, Chiba, Japan.

Yumi Murakami (Y)

NOV Academic Research, TOKIWA Pharmaceutical Co., Ltd., Tokyo, Japan.

Yumiko Saya (Y)

NOV Academic Research, TOKIWA Pharmaceutical Co., Ltd., Tokyo, Japan.

Hiroshi Matsunaka (H)

NOV Academic Research, TOKIWA Pharmaceutical Co., Ltd., Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH